17/01/2017
81 medicines recommended for approval, including 27 new active substances
The European Medicines Agency (EMA) has published an overview of its key recommendations of 2016 in relation to the marketing authorisationsof new medicines and the safety monitoring of authorised medicines.
In 2016, EMA recommended 81 medicines for marketing authorisation, including 27 new active substances.
A selection of these recommendations can be found in the human medicines highlights document released today.
EMA - European Medicines Agency published this content on 17 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 25 January 2017 14:52:02 UTC.
Original documenthttp://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/01/news_detail_002678.jsp&mid=WC0b01ac058004d5c1
Public permalinkhttp://www.publicnow.com/view/ED0C76734B8ADA5C48F7DBC413E9F40FE0A19BE1
